Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 207 of 5804
-
Brain zaps and yoga poses: new hope for Veterans' back pain?
Symptom relief Not yet recruitingThe objectives of this VA Merit application are to demonstrate efficacy of combined intermittent theta burst (iTBS) and yoga (iTBS+yoga) intervention on improving pain, function, analgesic use, self-efficacy, quality of life and well-being among Veterans with chronic low back pai…
Phase: PHASE3 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
Dissolvable scaffolds could save legs from amputation in major new trial
Disease control Not yet recruitingRESCUE is a Europe-wide study that will follow 400 people with critical limb-threatening ischemia (CLTI). It aims to see how well Esprit BTK™ Everolimus Eluting Resorbable Scaffolds work in real-life medical settings. The study focuses on people who have heavily calcified arterie…
Sponsor: Cardiovascular and Interventional Radiological Society of Europe • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Rural china tests smart wearables to stop heart failure before it starts
Prevention Recruiting nowThis cluster randomized study aims to compare village doctor-led integrated care versus usual care to improve cardiovascular health, atrial fibrillation management, self-management adherence, and heart failure prevention among older rural patients with atrial fibrillation in Chin…
Phase: NA • Sponsor: Jiangsu Taizhou People's Hospital • Aim: Prevention
Last updated Jul 16, 2026 00:00 UTC
-
Brain zaps tailored to you: new hope for PTSD?
Symptom relief Not yet recruitingThis study is testing a personalized form of brain stimulation called PrTMS as a treatment for post-traumatic stress disorder (PTSD) in military service members and veterans. Unlike standard approaches, this treatment uses a simple brainwave test (EEG) to tailor the therapy to ea…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Electric belly zaps may help spinal cord injury patients cough better
Disease control Not yet recruitingThe goal of this clinical trial is to learn if abdominal functional electrical stimulation (FES) using the VentFree Respiratory Muscle Stimulator improves cough strength in adults with a new spinal cord injury (SCI). It will also learn about the safety of abdominal FES in this po…
Phase: NA • Sponsor: Liberate Medical • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Smarter magnesium testing could shield Children's hearts and kidneys after surgery
Disease control Not yet recruitingLay Summary This study tests two ways of measuring blood magnesium after heart surgery. Children who need heart surgery may have heart and kidney problems after surgery. The right amount of magnesium in blood reduces this risk. This study will test the best way to measure magnes…
Phase: NA • Sponsor: West Virginia University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Smart missile drug takes aim at Hard-to-Treat prostate cancer
Disease control Not yet recruitingThis is an open-label, multicenter Phase 1 study of DEC003M, in patients with advanced stage prostate cancer. The study consists of a dose-escalation phase to determine the dose for expansion, followed by a dose-expansion phase to evaluate preliminary antitumor activity, safety, …
Phase: PHASE1 • Sponsor: Hangzhou DAC Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Sound and sight training may restore vision after stroke
Disease control Not yet recruitingDamage to visual cortex on one side of the brain frequently produces a profound and permanent blindness in contralesional space (hemianopia), a debilitating condition that causes enormous suffering for patients and their families.
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Smartphone therapy may ease anxiety for those with disabilities
Symptom relief Not yet recruitingThe purpose of this study is to see if a mobile-delivered mental health program called Toivoa-001, which combines digital cognitive behavioral therapy (CBT) with personal mental health coaching, can effectively reduce anxiety in adults with hearing or mobility disabilities. The s…
Phase: NA • Sponsor: Toivoa Inc • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Experimental drug targets rare cancer that often defies treatment
Disease control Not yet recruitingA Single-Arm, Non-Randomized, Open-Label Phase 2 Study of Nab-Sirolimus in Patients with Progressive or Symptomatic Epithelioid Hemangioendothelioma. Detailed Description: Avoid duplicating information that will be entered or uploaded elsewhere in the record.
Phase: PHASE2 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Triple-Drug cocktail aims to tackle esophageal cancer that resists standard therapy
Disease control Not yet recruitingImmunotherapy combined with chemotherapy has become the first-line standard of care for advanced esophageal squamous cell carcinoma (ESCC), significantly improving patient survival. However, with the widespread adoption of first-line immunotherapy, most patients eventually develo…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
AI tool aims to predict breast cancer drug success, sparing patients unnecessary side effects
Knowledge-focused Not yet recruitingThis study aims to develop an AI-based predictive tool to help clinicians more accurately determine whether breast cancer patients can benefit from HER-2-targeted antibody-drug conjugate (T-DXd) therapy before treatment. While HER-2-targeted ADC drugs have significantly improved …
Sponsor: Zhejiang Cancer Hospital • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Gene therapy for rare genetic syndrome moves to Long-Term safety check
Disease control ENROLLING_BY_INVITATIONThis is a long-term follow-up study of participants in the RB001-101 gene replacement therapy clinical trial for Children With SHANK3-related Phelan-McDermid Syndrome (PMS). Participants will roll over from the parent study into this long-term study for continuous safety monitori…
Phase: PHASE1 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Virus therapy aims to boost chemo in tough pancreatic cancer
Disease control Not yet recruitingThe goal of this clinical trial is to learn if the new administration regimen of VCN-01, given together with the standard chemotherapy drugs gemcitabine and nab-paclitaxel (GnP), is safe and well tolerated. The behaviour of VCN-01 in the organism will be assessed, together with t…
Phase: PHASE1, PHASE2 • Sponsor: Theriva Biologics SL • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New imaging tracer could spot hidden cancers and fibrosis in one scan
Diagnosis Not yet recruitingThis study is testing a new imaging tracer called \[18F\]FAPI-74 with PET scans. Researchers want to find out how well this tracer shows certain diseases in the body, including several types of cancer and some non-cancer conditions like fibrosis and sarcoidosis. \[18F\]FAPI-74 a…
Phase: PHASE1, PHASE2 • Sponsor: Martin Huellner • Aim: Diagnosis
Last updated Jul 17, 2026 00:00 UTC
-
Double attack on EGFR-Positive tumors: targeted drug plus immunotherapy combo tested
Disease control Recruiting nowThis phase II trial evaluates the combination of Becotatug Vedotin (MRG003), an EGFR-targeting ADC, and Pucotenlimab (HX008), a PD-1 inhibitor, in patients with high EGFR expressing advanced refractory solid tumors. The study is designed to assess clinical efficacy and safety, bu…
Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug cocktail aims to shrink Hard-to-Treat gut tumors
Disease control Not yet recruitingThis study is a single prospective, parallel, double-cohort, multicenter phase II clinical trial, aiming to evaluate the efficacy and safety of ivonescimab (AK112) combined with IP chemotherapy ± TACE in the first-line treatment of metastatic digestive system neuroendocrine cance…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a four-drug cocktail shrink hard-to-treat colorectal cancer?
Disease control Not yet recruitingPrimary endpoint: objective response rate Secondary endpoints: PFS, OS and adverse events
Phase: PHASE2 • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a targeted pill boost Chemo's power against a rare blood cancer?
Disease control Not yet recruitingThis is a single-arm, multicenter, Phase Ib/IIa study designed to explore the efficacy and safety of SHR2554 in combination with liposomal mitoxantrone for the treatment of patients with treatment-naive peripheral T-cell lymphoma (PTCL). The study is divided into a Phase Ib safet…
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could removing tonsils supercharge a sleep apnea implant?
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether removing the tonsils at the time of hypoglossal nerve stimulation improves treatment of obstructive sleep apnea in adults whose airway collapses from the side of the upper airway during sleep. The main questions it aims to answe…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC